CES1 and obesity due to melanocortin 4 receptor deficiency: Given the critical role of human CES1 (hCES1) in metabolizing cholesteryl esters, inhibitors of hCES1 have the potential to treat hypertriglyceridemia, obesity, type 2 diabetes and atherosclerosis [80,81,82,83].